Clinical and Epidemiological Research
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
Jump to comment:
We read with interest the study conducted by Galloway and colleagues on the risk of skin and soft tissue infections (SSTI) and herpes zoster (HZ) in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) antagonists versus non-biologic disease-modifying anti-rheumatic drugs (nbDMARDs). (1) This study highlights the occurrence of common infections such as SSTI and more unco...
We read with interest the report by Galloway et al on the risk of skin and soft tissue infections (including shingles) in patients exposed to TNF antagonists from the BSRBR . In the light of our recently published systematic literature review of the risk of shingles in rheumatoid arthritis (RA) patients, we would like to address several issues raised in the report . The authors state that the inci...